赛托生物
(300583)
| 流通市值：26.10亿 | | | 总市值：26.60亿 |
| 流通股本：1.86亿 | | | 总股本：1.90亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 228,434,285.54 | 271,715,631.89 | 229,945,988.16 | 255,962,580.48 |
| 应收票据及应收账款 | 234,690,640.95 | 247,179,997.53 | 251,322,996.55 | 201,425,299.6 |
| 应收账款 | 234,690,640.95 | 247,179,997.53 | 251,322,996.55 | 201,425,299.6 |
| 应收款项融资 | 202,580,318.73 | 170,420,065.3 | 139,453,648.22 | 135,282,379.06 |
| 预付款项 | 4,279,257.98 | 9,345,061.59 | 9,688,739.64 | 7,780,152.91 |
| 其他应收款合计 | 7,693,499.1 | 7,806,475.39 | 13,942,353.83 | 13,038,620.68 |
| 存货 | 495,950,182.87 | 515,354,334.55 | 550,279,833.26 | 644,877,938.66 |
| 其他流动资产 | 16,182,786.22 | 20,293,980.26 | 22,796,588.98 | 26,549,191.26 |
| 流动资产合计 | 1,189,810,971.39 | 1,242,115,546.51 | 1,217,430,148.64 | 1,284,916,162.65 |
| 非流动资产: | | | | |
| 长期股权投资 | 69,939,205.51 | 68,639,229.48 | 67,318,247.18 | 68,677,871.46 |
| 其他权益工具投资 | 3,000,000 | - | - | - |
| 固定资产 | 1,097,763,737.52 | 1,129,220,114.27 | 1,128,780,125.02 | 1,169,951,016.19 |
| 在建工程 | 302,864,587.19 | 279,221,920.31 | 307,842,847.95 | 281,700,000.48 |
| 使用权资产 | 1,607,229.22 | 1,360,368.12 | 8,206,498.97 | 9,008,011.8 |
| 无形资产 | 184,023,854.18 | 185,807,823.45 | 187,415,383.32 | 189,154,137.38 |
| 长期待摊费用 | 472,811.93 | - | 657,276.18 | 785,937.33 |
| 递延所得税资产 | 12,190,685.48 | 12,465,587.25 | 13,941,355.12 | 16,198,352.27 |
| 其他非流动资产 | 4,406,000 | 4,406,000 | 4,825,614.54 | 5,415,292.97 |
| 非流动资产合计 | 1,676,268,111.03 | 1,681,121,042.88 | 1,718,987,348.28 | 1,740,890,619.88 |
| 资产总计 | 2,866,079,082.42 | 2,923,236,589.39 | 2,936,417,496.92 | 3,025,806,782.53 |
| 流动负债: | | | | |
| 短期借款 | 661,216,449.4 | 665,927,402.23 | 662,574,103.57 | 642,556,170.71 |
| 应付票据及应付账款 | 258,700,364.33 | 266,435,685.26 | 235,766,608.31 | 307,429,290.64 |
| 其中：应付票据 | 111,312,158.63 | 97,917,835.58 | 86,009,926.41 | 136,427,270.65 |
| 应付账款 | 147,388,205.7 | 168,517,849.68 | 149,756,681.9 | 171,002,019.99 |
| 合同负债 | 3,119,274.46 | 5,292,479.25 | 4,032,803.61 | 4,790,455.65 |
| 应付职工薪酬 | 8,007,196.17 | 7,356,878.94 | 8,075,913.02 | 10,364,524.24 |
| 应交税费 | 7,811,293.84 | 9,289,397.23 | 8,557,583.88 | 4,336,418.44 |
| 其他应付款合计 | 16,669,183.58 | 15,933,098.48 | 16,714,283.58 | 14,519,575.38 |
| 一年内到期的非流动负债 | 26,888,824.14 | 37,342,812.33 | 40,146,255.84 | 39,152,925.84 |
| 其他流动负债 | 326,592.27 | 536,132.12 | 474,804.32 | 522,534.41 |
| 流动负债合计 | 982,739,178.19 | 1,008,113,885.84 | 976,342,356.13 | 1,023,671,895.31 |
| 非流动负债: | | | | |
| 长期借款 | 56,800,000 | 64,614,353.04 | 68,651,892.21 | 74,282,737.63 |
| 租赁负债 | 303,105.4 | 355,127.08 | 4,630,180.29 | 5,316,959.73 |
| 长期应付款 | 3,729,952.69 | 7,404,716.96 | 11,558,980.13 | 16,373,310.8 |
| 递延收益 | 20,717,118.03 | 19,743,680.06 | 22,412,740.78 | 21,329,376.67 |
| 递延所得税负债 | 547,345.71 | 573,258.27 | 609,338.36 | 667,552.85 |
| 非流动负债合计 | 82,097,521.83 | 92,691,135.41 | 107,863,131.77 | 117,969,937.68 |
| 负债合计 | 1,064,836,700.02 | 1,100,805,021.25 | 1,084,205,487.9 | 1,141,641,832.99 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 189,702,126 | 189,702,126 | 189,702,126 | 189,702,126 |
| 资本公积 | 1,276,956,870.47 | 1,276,956,870.47 | 1,276,956,870.47 | 1,276,956,870.47 |
| 盈余公积 | 93,766,209.97 | 93,766,209.97 | 93,766,209.97 | 93,766,209.97 |
| 未分配利润 | 205,672,011.77 | 224,112,175.52 | 251,187,826.15 | 278,696,334.13 |
| 归属于母公司股东权益合计 | 1,766,097,218.21 | 1,784,537,381.96 | 1,811,613,032.59 | 1,839,121,540.57 |
| 少数股东权益 | 35,145,164.19 | 37,894,186.18 | 40,598,976.43 | 45,043,408.97 |
| 股东权益合计 | 1,801,242,382.4 | 1,822,431,568.14 | 1,852,212,009.02 | 1,884,164,949.54 |
| 负债和股东权益合计 | 2,866,079,082.42 | 2,923,236,589.39 | 2,936,417,496.92 | 3,025,806,782.53 |
| 公告日期 | 2025-10-29 | 2025-08-26 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |